Controlling inflammation in the elderly with BCG vaccination.
| dc.contributor.author | Koeken, Valerie A C M | |
| dc.date.accessioned | 2021-09-09T09:16:39Z | |
| dc.date.available | 2021-09-09T09:16:39Z | |
| dc.date.issued | 2021-08-04 | |
| dc.identifier.citation | Sci Adv. 2021 Aug 4;7(32):eabk1668. doi: 10.1126/sciadv.abk1668. PMID: 34348906. | en_US |
| dc.identifier.pmid | 34348906 | |
| dc.identifier.doi | 10.1126/sciadv.abk1668 | |
| dc.identifier.uri | http://hdl.handle.net/10033/623020 | |
| dc.description.abstract | The tuberculosis vaccine BCG may protect against inflammation in the elderly as well as offer an option for protection from SARS-CoV-2 in developing countries. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | AAAS | en_US |
| dc.rights | Attribution 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.title | Controlling inflammation in the elderly with BCG vaccination. | en_US |
| dc.type | Article | en_US |
| dc.identifier.eissn | 2375-2548 | |
| dc.contributor.department | CiiM, Zentrum für individualisierte Infektionsmedizin, Feodor-Lynen-Str.7, 30625 Hannover. | en_US |
| dc.identifier.journal | Science advances | en_US |
| dc.source.volume | 7 | |
| dc.source.issue | 32 | |
| refterms.dateFOA | 2021-09-09T09:16:39Z | |
| dc.source.journaltitle | Science advances | |
| dc.source.country | United States |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution 4.0 International